Literature DB >> 19384166

Inadequate immune regulatory function of CD4+CD25bright+FoxP3+ T cells in heart transplant patients who experience acute cellular rejection.

I Esmé Dijke1, Sander S Korevaar, Kadir Caliskan, Aggie H M M Balk, Alex P W M Maat, Willem Weimar, Carla C Baan.   

Abstract

BACKGROUND: CD4CD25FoxP3 regulatory T cells are suppressors of antigen-activated immune reactivity. Here, we assessed the clinically relevant role of these cells in the control of immune responses directed to a transplanted heart.
METHODS: We investigated the phenotype and function of peripheral CD4CD25FoxP3 T cells in heart transplant patients free from acute rejections (n=9) and in rejectors (n=12) before and during acute cellular rejection.
RESULTS: Between rejectors and nonrejectors, the proportion of CD4CD25 T cells and of FoxP3 cells within this population was comparable. Yet, CD4CD25FoxP3 T cells of rejectors had a higher CD127 expression than those of nonrejectors (P<0.0001). Depletion of CD4CD25 T cells from peripheral blood mononuclear cells increased the antidonor proliferative response of both nonrejectors (P=0.0005) and rejectors (P=0.03). In rejectors, however, only a 2-fold increase was measured, whereas the nonrejectors' response became 14 times higher (P=0.002). Reconstitution of CD4CD25 T cells only suppressed the overall antidonor proliferative response of CD25 responder cells of nonrejectors significantly (P=0.001). Moreover, the percentage inhibition of the response was higher in nonrejectors than in rejectors (P=0.02). Analyses of pretransplant samples revealed that CD4CD25 T cells of rejectors already had a lower suppressive capacity than those of nonrejectors before transplantation (P=0.04).
CONCLUSION: CD4CD25FoxP3 T cells of heart transplant patients who experience acute rejection had an up-regulated CD127 expression and an inadequate regulatory function compared with those of nonrejecting patients. Our observations suggest that the function of circulating CD4CD25FoxP3 regulatory T cells may be pivotal for the prevention of acute cellular rejection after clinical heart transplantation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19384166     DOI: 10.1097/TP.0b013e31819ec2fb

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  9 in total

1.  Monitoring of CD4+CD25highIL-7Rαhigh activated T cells in kidney transplant recipients.

Authors:  Laure Vallotton; Karine Hadaya; Jean-Pierre Venetz; Leo H Buehler; Donatella Ciuffreda; Ghaleb Nseir; Laura Codarri; Jean Villard; Giuseppe Pantaleo; Manuel Pascual
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-14       Impact factor: 8.237

2.  Induction of antigen-specific immune tolerance by TGF-beta-induced CD4+Foxp3+ regulatory T cells.

Authors:  Huimin Fan; Julie Wang; Xiaohui Zhou; Zhongmin Liu; Song Guo Zheng
Journal:  Int J Clin Exp Med       Date:  2009-08-25

Review 3.  Detecting adaptive immunity: applications in transplantation monitoring.

Authors:  Georg A Böhmig; Markus Wahrmann; Marcus D Säemann
Journal:  Mol Diagn Ther       Date:  2010-02-01       Impact factor: 4.074

Review 4.  Monitoring alloimmune response in kidney transplantation.

Authors:  Oriol Bestard; Paolo Cravedi
Journal:  J Nephrol       Date:  2016-05-31       Impact factor: 3.902

5.  Differing effects of rapamycin or calcineurin inhibitor on T-regulatory cells in pediatric liver and kidney transplant recipients.

Authors:  T Akimova; B M Kamath; J W Goebel; K E C Meyers; E B Rand; A Hawkins; M H Levine; J C Bucuvalas; W W Hancock
Journal:  Am J Transplant       Date:  2012-09-20       Impact factor: 8.086

6.  DR(high+)CD45RA(-)-Tregs potentially affect the suppressive activity of the total Treg pool in renal transplant patients.

Authors:  Matthias Schaier; Nicole Seissler; Edgar Schmitt; Stefan Meuer; Friederike Hug; Martin Zeier; Andrea Steinborn
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

7.  Relevance of regulatory T cell promotion of donor-specific tolerance in solid organ transplantation.

Authors:  Pervinder Sagoo; Giovanna Lombardi; Robert I Lechler
Journal:  Front Immunol       Date:  2012-07-13       Impact factor: 7.561

8.  Fas, FasL and Foxp3 gene expression in post-liver transplant autoimmune hepatitis patients with and without acute rejection.

Authors:  Keivan Shams; Kurosh Kalantar; Mohammad Hossein Karimi; Meysam Nasiri; Afsoon Afshari; Zahra Amirghofran
Journal:  Clin Exp Hepatol       Date:  2019-05-13

9.  Case Report: A Case of Acute Cellular Rejection Due to Atopic Dermatitis Exacerbation 3 Years After Heart Transplantation.

Authors:  Nobutaka Kakuda; Eisuke Amiya; Masaru Hatano; Hisataka Maki; Chie Bujo; Masaki Tsuji; Koichi Narita; Kanna Fujita; Junichi Ishida; Minoru Ono; Issei Komuro
Journal:  Front Immunol       Date:  2021-02-22       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.